SKI Market

Indian Indices

Nifty

24,716.60 -34.10
(-0.14%)

Sensex

80,737.51 -636.24
( -0.78%)

Bank Nifty

55,903.40 153.70
( 0.28%)

Nifty IT

37,061.85 -259.90
( -0.70%)

Global Indices

Nasdaq

42,330.65 39.58
(0.09%)

Dow Jones

5,956.64 23.95
(0.40%)

Hang Seng

37,515.94 45.27
(0.12%)

Nikkei 225

8,774.26 1.88
(0.02%)

Forex

USD-INR

85.54 0.04
(0.05%)

EUR-INR

97.07 0.05
(0.06%)

GBP-INR

115.07 -0.11
(-0.10%)

JPY-INR

0.59 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

397.4448044

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

24.1

118702.95

EPS(TTM)

Face Value()

Div & Yield %

60.98

1.09

Back

Cipla announced incorporation of subsidiary - CiplaRna GmbH' in Germany

May 29,2025

Cipla announced that Cipla (EU), UK, a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary named ‘CiplaRna GmbH' in Germany, effective 28 May 2025.

CiplaRna has been incorporated with the objective of establishing a laboratory for mRNA-based formulation and drug development support.

24,716.60 -34.10 (-0.14%)

80,737.51 -636.24 ( -0.78%)

55,903.40 153.70 ( 0.28%)

37,061.85 -259.90 ( -0.70%)

42,330.65 39.58 (0.09%)

5,956.64 23.95 (0.40%)

37,515.94 45.27 (0.12%)

8,774.26 1.88 (0.02%)

85.54 0.04 (0.05%)

97.07 0.05 (0.06%)

115.07 -0.11 (-0.10%)

0.59 0.00 (-0.04%)